The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that its Sentri7® solution has received the 2017 Category Leader award for Clinical Decision Support-Surveillance in the 2017 Best in KLAS: Software & Services report. Having captured the Category Leader designation in two previous Best in KLAS reports, the clinical surveillance and decision support platform was awarded top honors for: general satisfaction; functionality and upgrades; and sales and contracting.
Utilizing algorithms to prevent bias, KLAS partners with healthcare providers to provide insight into the quality of healthcare technology solutions. Based on the aggregated feedback of thousands of healthcare professionals and clinicians, the Best in KLAS annual report recognizes the best-performing healthcare IT vendors in more than 100 market segments to ultimately improve vendor performance and guide healthcare provider buying decisions.
Sentri7 drives continuous improvement by leveraging EMR investments to empower clinicians to operate smarter and more efficiently. An interoperable SaaS platform, the HIPAA-compliant clinical decision support surveillance solution provides real-time aggregation of patient data to automate tracking, identification and reporting of patient issues to enable proactive governance and management of critical clinical initiatives such as Antimicrobial Stewardship. Sentri7 clinical content is created and maintained by clinicians and put through a rigorous editorial process that synthesizes the most up-to-date medical information into accurate, trusted, evidence-based alerts and care recommendations designed to achieve important clinical outcomes.
“Hospitals and healthcare organizations are increasingly turning towards clinical surveillance solutions to comply with federal and state regulations, as well as transition to value-based care,” said David A. Del Toro, President & CEO of Clinical Software Solutions at Wolters Kluwer. “It is a great honor to have Sentri7 once again recognized by our customers through KLAS as an impactful intervention that aids in providing optimal care.”
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.